公开(公告)号：EP3915539A1

公开(公告)日：2021-12-01

申请号：EP21169956.6

申请日：2019-01-09

申请人： FAES FARMA, S.A.

发明人： HERNÁNDEZ HERRERO, Gonzalo ,  GONZALO GOROSTIZA, Ana ,  MORÁN POLADURA, Pablo ,  ZAZPE ARCE, Arturo ,  FERNÁNDEZ HERNANDO, Nieves ,  GONZÁLEZ GARCÍA, Tania ,  TATO CERDEIRAS, Paloma ,  OTERO ESPINAR, Francisco Javier ,  FERNÁNDEZ FERREIRO, Anxo ,  DÍAZ TOMÉ, Victoria

IPC分类号： A61K9/00 ,  A61K47/40 ,  A61K31/454 ,  A61P27/14

摘要： The invention relates to an aqueous ophthalmic pharmaceutical composition comprising:
a) at least 0.4% w/v of bilastine, of formula

or a pharmaceutically acceptable salt or solvate thereof, wherein the bilastine salt or solvate thereof is completely dissolved in the pharmaceutical composition;
b) at least one β-cyclodextrin; and
c) at least one pharmaceutically acceptable water-soluble gelling agent;
and wherein the pH is comprised between 4 and 9.
and its use in the treatment and/or prevention of conditions mediated by H 1 histamine receptor, such as allergic disorders or diseases. The invention relates to the treatment and/or prevention of allergic conjunctivitis.

公开(公告)号：EP3740191A1

公开(公告)日：2020-11-25

申请号：EP19701154.7

申请日：2019-01-09

申请人： FAES FARMA, S.A.

发明人： HERNÁNDEZ HERRERO, Gonzalo ,  GONZALO GOROSTIZA, Ana ,  MORÁN POLADURA, Pablo ,  ZAZPE ARCE, Arturo ,  FERNÁNDEZ HERNANDO, Nieves ,  GONZÁLEZ GARCÍA, Tania ,  TATO CERDEIRAS, Paloma ,  OTERO ESPINAR, Francisco Javier ,  FERNÁNDEZ FERREIRO, Anxo ,  DÍAZ TOMÉ, Victoria

IPC分类号： A61K9/00 ,  A61K47/40 ,  A61K31/454 ,  A61P27/14